Correlation Between Acumen Pharmaceuticals and RF Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and RF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and RF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and RF Acquisition Corp, you can compare the effects of market volatilities on Acumen Pharmaceuticals and RF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of RF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and RF Acquisition.

Diversification Opportunities for Acumen Pharmaceuticals and RF Acquisition

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Acumen and RFACR is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and RF Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RF Acquisition Corp and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with RF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RF Acquisition Corp has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and RF Acquisition go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and RF Acquisition

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the RF Acquisition. But the stock apears to be less risky and, when comparing its historical volatility, Acumen Pharmaceuticals is 35.3 times less risky than RF Acquisition. The stock trades about 0.0 of its potential returns per unit of risk. The RF Acquisition Corp is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  8.01  in RF Acquisition Corp on September 14, 2024 and sell it today you would earn a total of  5.99  from holding RF Acquisition Corp or generate 74.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy37.65%
ValuesDaily Returns

Acumen Pharmaceuticals  vs.  RF Acquisition Corp

 Performance 
       Timeline  
Acumen Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
RF Acquisition Corp 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RF Acquisition Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain fundamental indicators, RF Acquisition reported solid returns over the last few months and may actually be approaching a breakup point.

Acumen Pharmaceuticals and RF Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acumen Pharmaceuticals and RF Acquisition

The main advantage of trading using opposite Acumen Pharmaceuticals and RF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, RF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RF Acquisition will offset losses from the drop in RF Acquisition's long position.
The idea behind Acumen Pharmaceuticals and RF Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios